首页 › 胰腺癌 › 南卡罗来纳州 › Charleston
Charleston SC 胰腺癌临床试验
7项针对 胰腺癌的研究正在 Charleston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
招募中3 期
- Investigative Site US082, Charleston
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
招募中观察性研究
- Roper Hospital, Charleston
- Bon Secours Saint Francis Hospital, Charleston
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
招募中3 期
- Medical University of South Carolina, Charleston
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
招募中2 期
- Medical University of South Carolina, Charleston
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
招募中2 期
- Ohio State University-Telemedicine, Charleston
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
招募中观察性研究欢迎健康志愿者
- Medical University of South Carolina, Charleston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
招募中1 期
- Medical University of South Carolina, Hollings Cancer Center, Charleston
其他城市的 胰腺癌试验
- Houston, TX61 项研究
- New York City, NY60 项研究
- Boston, MA43 项研究
- Nashville, TN39 项研究
- Los Angeles, CA35 项研究
- St. Louis, MO33 项研究
- Arlington, VA33 项研究
- Baltimore, MD31 项研究
- San Antonio, TX31 项研究
- Philadelphia, PA26 项研究
- Tampa, FL26 项研究
- Durham, NC24 项研究
Charleston的其他研究
- 抑郁症19 项研究
- 卒中18 项研究
- 心力衰竭18 项研究
- 非小细胞肺癌16 项研究
- 创伤后应激障碍16 项研究
- 心血管疾病15 项研究
- 前列腺癌15 项研究
- 癌症(所有类型)14 项研究
- 头颈鳞状细胞癌14 项研究
- 帕金森病13 项研究
- 间质性肺病13 项研究
- 乳腺癌12 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。